Showing 1 - 10 of 71
We develop a simultaneous equations estimation framework to understand the interactions among generic entry, prices, and market shares. We base our estimates on a panel data sample of 40 brand-name drugs that first experienced generic competition during the period July 1992-January 1998. We find...
Persistent link: https://www.econbiz.de/10005471731
Background: Conservative estimates indicate between 10% and 20% of all individuals with major depressive disorders (MDDs) fail to respond to conventional antidepressant therapies. Amongst those with MDD, individuals with treatment-resistant depression (TRD) have been found to be frequent users...
Persistent link: https://www.econbiz.de/10005404979
Persistent link: https://www.econbiz.de/10005371931
Background: While there is some literature on the cost of specific respiratory infections, much of the existing research focuses only on direct medical treatment costs and does not take into consideration workplace burden due to disability and absenteeism. Objective: To evaluate the impact of...
Persistent link: https://www.econbiz.de/10005404783
Persistent link: https://www.econbiz.de/10011152281
Persistent link: https://www.econbiz.de/10005404780
Persistent link: https://www.econbiz.de/10010797399
CTEPH patients had substantially higher costs and co-morbidity than matched controls, with circulatory-/respiratory-related costs accounting for 55% of excess costs. The high burden of illness suggests opportunities for savings from improved management. </AbstractSection> Copyright Adis Data Information BV 2011
Persistent link: https://www.econbiz.de/10011000726
The cost of early retirement associated with patients with PD was substantial. Given that the proportion of Americans participating in the labour force in older age groups is expected to increase, PD-related early retirement costs will likely rise. </AbstractSection> Copyright Adis Data Information BV 2011
Persistent link: https://www.econbiz.de/10011000779
Compared with controls, Medicaid AD patients incurred higher acute care costs in the 12 months prior to their preliminary diagnosis, suggesting room for beneficial interventions and better disease management should earlier diagnosis become possible. These findings may be especially relevant in...
Persistent link: https://www.econbiz.de/10011000806